Actinogen Medical Ltd (ACW) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.507x

Based on the latest financial reports, Actinogen Medical Ltd (ACW) has a cash flow conversion efficiency ratio of -0.507x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.29 Million ≈ $-6.58 Million USD) by net assets (AU$18.34 Million ≈ $12.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Actinogen Medical Ltd (ACW) balance sheet quality index to measure how much of total assets are equity-financed.

Actinogen Medical Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Actinogen Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ACW capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Actinogen Medical Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Actinogen Medical Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kron Telekomunikasyon Hizmetleri AS IS:KRONT	0.156x
Atturra Ltd AU:ATA	-0.061x
Yirendai Ltd NYSE:YRD	-0.001x
In The F KO:014990	0.009x
Yoosung T&S Co. Ltd KQ:024800	0.004x
Vita Life Sciences Ltd AU:VLS	0.125x
J Sainsbury PLC LSE:SBRY	0.419x
MIC Electronics Limited NSE:MICEL	0.001x

Annual Cash Flow Conversion Efficiency for Actinogen Medical Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Actinogen Medical Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Actinogen Medical Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$18.34 Million ≈ $12.97 Million	AU$-7.56 Million ≈ $-5.35 Million	-0.412x	+52.12%
2024-06-30	AU$19.70 Million ≈ $13.94 Million	AU$-16.95 Million ≈ $-11.99 Million	-0.861x	-32.65%
2023-06-30	AU$13.41 Million ≈ $9.49 Million	AU$-8.70 Million ≈ $-6.15 Million	-0.649x	-48.20%
2022-06-30	AU$21.74 Million ≈ $15.38 Million	AU$-9.52 Million ≈ $-6.73 Million	-0.438x	-343.34%
2021-06-30	AU$17.46 Million ≈ $12.35 Million	AU$-1.72 Million ≈ $-1.22 Million	-0.099x	+62.35%
2020-06-30	AU$10.89 Million ≈ $7.70 Million	AU$-2.86 Million ≈ $-2.02 Million	-0.262x	+60.87%
2019-06-30	AU$15.66 Million ≈ $11.08 Million	AU$-10.50 Million ≈ $-7.43 Million	-0.670x	-46.20%
2018-06-30	AU$17.26 Million ≈ $12.21 Million	AU$-7.91 Million ≈ $-5.60 Million	-0.458x	-287.20%
2017-06-30	AU$9.37 Million ≈ $6.63 Million	AU$-1.11 Million ≈ $-784.55K	-0.118x	+71.51%
2016-06-30	AU$12.13 Million ≈ $8.58 Million	AU$-5.04 Million ≈ $-3.57 Million	-0.416x	-71.57%
2015-06-30	AU$15.36 Million ≈ $10.87 Million	AU$-3.72 Million ≈ $-2.63 Million	-0.242x	+32.96%
2014-06-30	AU$1.21 Million ≈ $857.43K	AU$-437.84K ≈ $-309.80K	-0.361x	+44.08%
2013-06-30	AU$194.35K ≈ $137.52K	AU$-125.56K ≈ $-88.85K	-0.646x	+72.79%
2012-06-30	AU$346.99K ≈ $245.52K	AU$-823.94K ≈ $-582.99K	-2.375x	-208.31%
2011-06-30	AU$1.05 Million ≈ $740.20K	AU$-805.70K ≈ $-570.09K	-0.770x	-23.70%
2010-06-30	AU$1.17 Million ≈ $826.62K	AU$-727.37K ≈ $-514.66K	-0.623x	-116.57%
2009-06-30	AU$1.90 Million ≈ $1.35 Million	AU$-546.87K ≈ $-386.95K	-0.287x	-106.93%
2008-06-30	AU$2.86 Million ≈ $2.02 Million	AU$-397.22K ≈ $-281.06K	-0.139x	--

About Actinogen Medical Ltd

AU:ACW Australia Biotechnology

Market Cap

$96.71 Million

AU$136.67 Million AUD

Market Cap Rank

#19312 Global

#618 in Australia

Share Price

AU$0.04

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.07

All Time High

AU$0.18